Allotex

Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia and hyperopia. The therapy is accomplished through tissue addition technology that uses precisely shaped human corneal allografts to create what is essentially a permanent, living contact lens or lens insert. Allotex is a clinical stage company led by Drs. David Muller and Michael Mrochen.